Literature DB >> 212581

Rebinding of transcriptase components (L and NS proteins) to the nucleocapsid template of vesicular stomatitis virus.

M G Mellon, S U Emerson.   

Abstract

The L and NS proteins of vesicular stomatitis virions (New Jersey serotype) were solubilized with Triton X-100 and high-salt buffer and recombined with purified nucleocapsids under conditions similar to those used to reconstitute transcriptase activity in vitro. The nucleocapsid-bound L and NS proteins were separated from unbound proteins on a glycerol gradient. The rebinding of L and NS proteins mimics the in vivo binding in that at saturation the ratio of L and NS molecules to N molecules is approximately the same as observed in the intact virion. L and NS proteins were separated and added back independently and in combination to the template. The purified NS protein bound to the template in the absence of L protein. However, the L protein binding appeared to depend on the presence of NS protein. The presence of Mg2+ and nucleotides, which is required for transcription, was not necessary for the rebinding of L and NS proteins.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 212581      PMCID: PMC525842     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  13 in total

1.  The nature of the RNA products synthesized in vitro by subviral components of visicular stomatitis virus.

Authors:  G Abraham; A K Banerjee
Journal:  Virology       Date:  1976-05       Impact factor: 3.616

2.  RNA- temperature-sensitive mutants of vesicular stomatitis virus: L-protein thermosensitivity accounts for transcriptase restriction of group I mutants.

Authors:  D M Hunt; S U Emerson; R R Wagner
Journal:  J Virol       Date:  1976-05       Impact factor: 5.103

3.  Transcriptional mapping of vesicular stomatitis virus in vivo.

Authors:  L A Ball
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

4.  Function and structure of RNA polymerase from vesicular stomatitis virus.

Authors:  S Naito; A Ishihama
Journal:  J Biol Chem       Date:  1976-07-25       Impact factor: 5.157

5.  L protein requirement for in vitro RNA synthesis by vesicular stomatitis virus.

Authors:  S U Emerson; R R Wagner
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

6.  The fine structure of vesicular stomatitis virus.

Authors:  T Nakai; A F Howatson
Journal:  Virology       Date:  1968-06       Impact factor: 3.616

7.  Classification of the New Jersey serotype of vesicular stomatitis virus into two subtypes.

Authors:  M E Reichmann; W M Schnitzlein; D H Bishop; R A Lazzerini; S T Beatrice; R R Wagner
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

8.  Dissociation and reconstitution of the transcriptase and template activities of vesicular stomatitis B and T virions.

Authors:  S U Emerson; R R Wagner
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

9.  Dissociation of vesicular stomatitis virus and relation of the virion proteins to the viral transcriptase.

Authors:  D H Bishop; P Roy
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

10.  Reconstitution of infectivity and transcriptase activity of homologous and heterologous viruses: vesicular stomatitis (Indiana serotype), Chandipura, vesicular stomatitis (New Jersey serotype), and Cocal viruses.

Authors:  D H Bishop; S U Emerson; A Flamand
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

View more
  44 in total

1.  Structure of the RNA inside the vesicular stomatitis virus nucleocapsid.

Authors:  F Iseni; F Baudin; D Blondel; R W Ruigrok
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

2.  Mechanism of RNA synthesis initiation by the vesicular stomatitis virus polymerase.

Authors:  Benjamin Morin; Amal A Rahmeh; Sean P J Whelan
Journal:  EMBO J       Date:  2012-01-13       Impact factor: 11.598

3.  The importance of the NP: VP35 ratio in Ebola virus nucleocapsid formation.

Authors:  Takeshi Noda; Larissa Kolesnikova; Stephan Becker; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

4.  An amino acid of human parainfluenza virus type 3 nucleoprotein is critical for template function and cytoplasmic inclusion body formation.

Authors:  Shengwei Zhang; Longyun Chen; Guangyuan Zhang; Qin Yan; Xiaodan Yang; Binbin Ding; Qiaopeng Tang; Shengjun Sun; Zhulong Hu; Mingzhou Chen
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

5.  Mutations in the C-terminal loop of the nucleocapsid protein affect vesicular stomatitis virus RNA replication and transcription differentially.

Authors:  Djamila Harouaka; Gail W Wertz
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

6.  Second-site mutations selected in transcriptional regulatory sequences compensate for engineered mutations in the vesicular stomatitis virus nucleocapsid protein.

Authors:  Djamila Harouaka; Gail W Wertz
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

7.  Structural and functional properties of the vesicular stomatitis virus nucleoprotein-RNA complex as revealed by proteolytic digestion.

Authors:  Anindya Sarkar; Santanu Chattopadhyay; Robert Cox; Ming Luo; Amiya K Banerjee
Journal:  Virology       Date:  2010-03-05       Impact factor: 3.616

8.  A role for the Sendai virus P protein trimer in RNA synthesis.

Authors:  J Curran
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

9.  Critical phosphoprotein elements that regulate polymerase architecture and function in vesicular stomatitis virus.

Authors:  Amal A Rahmeh; Benjamin Morin; Andreas D Schenk; Bo Liang; Bianca S Heinrich; Vesna Brusic; Thomas Walz; Sean P J Whelan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

10.  Specific interactions of vesicular stomatitis virus L and NS proteins with heterologous genome ribonucleoprotein template lead to mRNA synthesis in vitro.

Authors:  B P De; A K Banerjee
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.